🇺🇸 FDA
Pipeline program

CMOP±R

CSPC-DED-NHL-K03

Phase 2 small_molecule active

Quick answer

CMOP±R for NHL is a Phase 2 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
NHL
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials